List of Excipients in API carbachol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing carbachol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | MIOSTAT | carbachol | 0065-0023 | CALCIUM CHLORIDE | |
| Alcon Laboratories Inc | MIOSTAT | carbachol | 0065-0023 | HYDROCHLORIC ACID | |
| Alcon Laboratories Inc | MIOSTAT | carbachol | 0065-0023 | MAGNESIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for carbachol
Excipient focus: CALCIUM CHLORIDE
carbachol drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
carbachol drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
carbachol drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
carbachol drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
carbachol drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
carbachol drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
carbachol drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
carbachol drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
carbachol drug variants containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
carbachol drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
carbachol drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
carbachol drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | carbachol | 0065-0023 |
| Visus Therapeutics Inc | carbachol and brimonidine tartrate | 84892-275 |
| >Company | >Ingredient | >NDC |
carbachol drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch